Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,233,439
+$484,944 QoQ
Shares Held
24,544
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#1,457
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. JNJ ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,233,439 | 24,544 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,748,495 | 23,517 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,798,135 | 23,185 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,970,057 | 16,018 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $2,284,987 | 14,959 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,533,537 | 15,277 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,185,497 | 15,112 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,495,399 | 15,398 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,374,661 | 16,247 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,917,339 | 18,442 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,062,072 | 19,536 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,026,845 | 19,434 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,400,277 | 20,543 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,240,120 | 20,904 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,448,914 | 19,524 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $3,262,462 | 19,971 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,535,111 | 19,915 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,506,318 | 19,784 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,275,990 | 19,150 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $3,068,015 | 18,997 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $3,000,574 | 18,214 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,787,211 | 16,959 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,579,458 | 16,390 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||